Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Aug 14, 2026
Reporting period
Not applicable
Filed with the SEC
Aug 17, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001213900-26-090509
Filed / recorded
Aug 17, 2026, 4:16 PM UTC
Added to OQRO
Oct 8, 2026, 9:22 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
IceCure Medical Ltd.
Issuer CIK
1584371
Ticker
ICCM
Reporting person
Shay Levav
Relationship
Officer
Officer title
Chief Operating Officer
Security
Ordinary Shares
Table
Non-derivative (Table I)
Transaction date
Aug 14, 2026
Transaction code
A
Shares / units
141,483
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
146,303
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents (i) 141,483 restricted share units ("RSUs") granted on August 14, 2026, 25% of which vest on August 11, 2027, and the remaining 75% vest in twelve equal quarterly installments of 6.25% thereafter, (ii) 2,727 RSUs granted on July 2, 2024, 25% of which vested on July 29, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, (iii) 1,447 RSUs granted on November 5, 2025, 25% of which vest on November 5, 2026, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter, and (iv) 646 RSUs granted on March 16, 2026, 25% of which vest on March 16, 2027, and the remaining 75% vest in equal quarterly installments of 6.25% thereafter. Except for the 25% tranche of the RSUs granted on July 2, 2024 that vested on July 29, 2026, all of the foregoing RSUs remain unvested as of August 13, 2026. The holdings described in clauses (ii) through (iv) have been adjusted to reflect the Issuer's 1-for-30 reverse share split.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.